| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/09/2001 | EP1097720A1 Antiviral agent for use in treatment of cancer |
| 05/09/2001 | EP1097714A1 Composition for use in the treatment of tumours and the immunization of humans and animals |
| 05/09/2001 | EP1097241A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 05/09/2001 | EP1097210A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 05/09/2001 | EP1097208A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 05/09/2001 | EP1097203A1 Human presenilin-associated protein |
| 05/09/2001 | EP1097202A2 Human transport protein homologs |
| 05/09/2001 | EP1097201A1 Snurpotine i human m 3?g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 05/09/2001 | EP1097198A2 Soluble derivatives of anti-angiogenic peptides |
| 05/09/2001 | EP1097168A2 Compounds and methods for modulating cadherin-mediated functions |
| 05/09/2001 | EP1097165A1 Novel inhibitors of angiogenesis and tumor growth |
| 05/09/2001 | EP1097159A1 Phosphinous and phosphonic acid derivatives used as medicaments |
| 05/09/2001 | EP1097150A1 Imidazolyl derivatives |
| 05/09/2001 | EP1097147A1 Novel angiogenesis inhibitors |
| 05/09/2001 | EP1097138A1 Pharmaceutical compositions comprising 2-quinolones |
| 05/09/2001 | EP1097127A1 Diacylhydrazine derivatives as integrin inhibitors |
| 05/09/2001 | EP1096955A2 Cancer treatment methods using antibodies to aminophospholipids |
| 05/09/2001 | EP1096953A1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
| 05/09/2001 | EP1096946A2 Delta cleavage products and methods based thereon |
| 05/09/2001 | EP1096945A1 Lysine binding fragments of angiostatin |
| 05/09/2001 | EP1096943A1 Method of preparation and pharmaceutical composition of an uncaria water soluble extract |
| 05/09/2001 | EP1096930A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 05/09/2001 | EP1096929A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 05/09/2001 | EP0749432B1 9-deoxotaxane compounds |
| 05/09/2001 | EP0684842B1 Composition for use in the treatment of tumours and the immunization of humans and animals |
| 05/09/2001 | CN1294630A Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth |
| 05/09/2001 | CN1294579A Sulfonamide-contg. indole compounds |
| 05/09/2001 | CN1294517A Immunoglobulin molecules having synthetic variable region and modified specificity |
| 05/09/2001 | CN1294516A Antitumor compsn. contg. synergistic compsn. of anthracycline derivative with camptothecin derivate |
| 05/09/2001 | CN1294196A Immune stimulated holoside substance of bacterial strain from wood layer hole strain and its application |
| 05/09/2001 | CN1294133A Process for extracting cordycepin and its preparation |
| 05/09/2001 | CN1294001A Uropoly acid-peptide composition |
| 05/09/2001 | CN1294000A Process for preparing uropoly acid-peptide composition |
| 05/09/2001 | CN1293978A Antineoplastic Chinese medicine 'Zeqi' |
| 05/09/2001 | CN1293964A Chinese medicine for treating cancers and its preparing process |
| 05/09/2001 | CN1293959A Uropoly aic-peptide composition and its usage |
| 05/09/2001 | CN1065537C Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compsns contg. them |
| 05/09/2001 | CN1065438C Cyclic adhesion inhibitors |
| 05/08/2001 | US6229025 Process for alkylating hindered sulfonamides |
| 05/08/2001 | US6229016 Method for treating tumors using 2-aryl-naphthyridin-4-ones |
| 05/08/2001 | US6229015 Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
| 05/08/2001 | US6229002 Complex of nucleic acid which binds to platelet derived growth factor and nonimmunogenic, high molecular weight compound; for targeted diagnostic and therapy; anticarcinogenic agents; cardiovascular disorders; kidney disease |
| 05/08/2001 | US6228991 Amino acid sequence; diagnosis, treatment or prevention of reproductive, developmental, neoplastic, and immunological/ autoimmune disorders; anticarcinogenic agents; antitumor/antiarthrtic/antidiabetic agents; endometriosis |
| 05/08/2001 | US6228987 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 05/08/2001 | US6228982 Stable compounds that form double-stranded, helical structures mimicking double-stranded dna; diagnosis; prophylaxis; therapy; antisense agents |
| 05/08/2001 | US6228890 Use of alicyclic diamines as immunomodulators |
| 05/08/2001 | US6228889 Methods for treatment of conditions associated with lactosylceramide |
| 05/08/2001 | US6228877 Anticarcinogenic, antitumor and antiproliferative agents |
| 05/08/2001 | US6228876 Administering 1-(1,3-dioxolan-2-ylmethy)l- or 1-(1,3-dioxan-2-ylmethyl)-1h-1,2,4-triazole derivative |
| 05/08/2001 | US6228872 Neurotrophic diamide and carbamate agents |
| 05/08/2001 | US6228868 Anticarcinogenic and antitumor agents |
| 05/08/2001 | US6228865 Compounds useful for inhibition of farnesyl protein transferase |
| 05/08/2001 | US6228856 Compounds useful for inhibition of farnesyl protein transferase |
| 05/08/2001 | US6228855 Topoisomerase inhibitors; antitumor agents |
| 05/08/2001 | US6228837 Endothelial monocyte activating polypeptide II: a mediator which activates host response |
| 05/08/2001 | US6228834 Treating gramnegative bacterial infections; neutralizing lipopolysaccharides |
| 05/08/2001 | US6228616 Human anion channel |
| 05/08/2001 | US6228373 Peptide dimer, glycine, cystine or prolne amino acid for immunology |
| 05/08/2001 | US6228370 Antitumor agents |
| 05/08/2001 | US6228362 Boron neutron capture therapy using pre-targeting methods |
| 05/08/2001 | US6228361 Antisticking agents to prevent bonding |
| 05/08/2001 | US6228357 Cancer therapy using an oncogene product and a foreign MHC molecule |
| 05/08/2001 | US6227304 Upper hitch link |
| 05/08/2001 | US6227195 Coarse spray delivery of functional biologic material |
| 05/03/2001 | WO2001031580A2 Methods and devices for identifying patterns in biological systems |
| 05/03/2001 | WO2001031343A2 Diagnosis and therapy of cancer using sgp28-related molecules |
| 05/03/2001 | WO2001031051A2 Antisense modulation of protein kinase c-theta expression |
| 05/03/2001 | WO2001031046A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 05/03/2001 | WO2001031036A2 Modified viral surface proteins which bind to cells of tumor vasculature |
| 05/03/2001 | WO2001031029A2 Human sphingosine kinase gene |
| 05/03/2001 | WO2001031016A2 Processed human chemokines phc-1 and phc-2 |
| 05/03/2001 | WO2001031015A2 36p6d5: secreted tumor antigen |
| 05/03/2001 | WO2001031007A2 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/03/2001 | WO2001031005A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | WO2001031003A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | WO2001030987A2 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 05/03/2001 | WO2001030854A2 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 05/03/2001 | WO2001030847A1 Modified gp100 and uses thereof |
| 05/03/2001 | WO2001030843A1 Ligand activated transcriptional regulator proteins |
| 05/03/2001 | WO2001030842A1 A new polypeptide-zinc finger protein 36 and the polynucleotide encoding it |
| 05/03/2001 | WO2001030841A1 A new polypeptide-zinc finger protein 60 and the polynucleotide encoding it |
| 05/03/2001 | WO2001030840A1 A new polypeptide-zinc finger protein 57 and the polynucleotide encoding it |
| 05/03/2001 | WO2001030834A1 A new polypeptide-zinc finger protein 33 and the polynucleotide encoding it |
| 05/03/2001 | WO2001030832A1 A new polypeptide-zinc finger protein hkznf-23 and the polynucleotide encoding it |
| 05/03/2001 | WO2001030828A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 05/03/2001 | WO2001030804A2 Salt form of a conjugate useful in the treatment of prostate cancer |
| 05/03/2001 | WO2001030803A1 B-homoestra-1,3,5(10)-trienes as modulators of tubulin polymerization |
| 05/03/2001 | WO2001030801A1 Antisense modulation of integrin-linked kinase expression |
| 05/03/2001 | WO2001030790A1 Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer |
| 05/03/2001 | WO2001030789A1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 05/03/2001 | WO2001030781A2 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION |
| 05/03/2001 | WO2001030776A1 Novel limonoids for use particularly in the treatment of cancer and method for producing the same |
| 05/03/2001 | WO2001030774A1 Substituted indoles for modulating nfkb activity |
| 05/03/2001 | WO2001030772A1 Compounds and their use as cysteine protease inhibitors |
| 05/03/2001 | WO2001030771A1 Thiazolidinedione derivatives |
| 05/03/2001 | WO2001030768A1 Methods and compositions utilizing quinazolinones |
| 05/03/2001 | WO2001030767A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 05/03/2001 | WO2001030765A2 Method for producing therapeutic agents for ulcers |
| 05/03/2001 | WO2001030764A1 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof |
| 05/03/2001 | WO2001030763A1 Process for producing optically active naphthalene derivative and optical resolver therefor |